- Home
- PBA vs BNTX Comparison
PBA vs BNTX Comparison
Compare PBA & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBA
- BNTX
- Stock Information
- Founded
- PBA 1997
- BNTX 2008
- Country
- PBA Canada
- BNTX Germany
- Employees
- PBA N/A
- BNTX N/A
- Industry
- PBA Oil & Gas Production
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PBA Energy
- BNTX Health Care
- Exchange
- PBA Nasdaq
- BNTX Nasdaq
- Market Cap
- PBA 21.8B
- BNTX 25.0B
- IPO Year
- PBA N/A
- BNTX 2019
- Fundamental
- Price
- PBA $37.55
- BNTX $106.47
- Analyst Decision
- PBA Buy
- BNTX Strong Buy
- Analyst Count
- PBA 1
- BNTX 18
- Target Price
- PBA $59.00
- BNTX $141.55
- AVG Volume (30 Days)
- PBA 1.6M
- BNTX 1.1M
- Earning Date
- PBA 08-07-2025
- BNTX 08-04-2025
- Dividend Yield
- PBA 5.31%
- BNTX N/A
- EPS Growth
- PBA N/A
- BNTX N/A
- EPS
- PBA 2.13
- BNTX N/A
- Revenue
- PBA $5,653,459,489.00
- BNTX $2,968,331,171.00
- Revenue This Year
- PBA $13.50
- BNTX N/A
- Revenue Next Year
- PBA $0.62
- BNTX $10.68
- P/E Ratio
- PBA $17.61
- BNTX N/A
- Revenue Growth
- PBA 29.95
- BNTX 0.61
- 52 Week Low
- PBA $34.13
- BNTX $76.53
- 52 Week High
- PBA $43.44
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- PBA 47.35
- BNTX 53.76
- Support Level
- PBA $36.53
- BNTX $102.57
- Resistance Level
- PBA $38.07
- BNTX $107.51
- Average True Range (ATR)
- PBA 0.74
- BNTX 2.83
- MACD
- PBA -0.02
- BNTX -0.25
- Stochastic Oscillator
- PBA 29.64
- BNTX 56.58
About PBA Pembina Pipeline Corp. (Canada)
Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its operations include transmission pipelines, oil and gas gathering, fractionation, storage, and natural gas liquid exports.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.